Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added. Revision: v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:09:28.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:13:05.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3; core study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:35.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    An updated site revision tag (v3.4.2) was added, and an existing government funding status notice (v3.4.1) was removed. The study’s content and data remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T02:13:35.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A government funding notice and status update were added to the page footer. The site revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:39:25.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0). Removed the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T00:27:39.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.